文献速递细菌感染、耐药与抗菌药物医院感染防控

信号与噪声:如何分析微生物组并推进抗菌药物耐药性研究

Signal Versus Noise: How to Analyze the Microbiome and Make Progress on Antimicrobial Resistance.
PubMed 文献 · J Infect Dis · 2021-01-01

本文探讨肠道微生物组在抗菌药物耐药菌(ARO)定植风险和防御中的作用,借鉴艰难梭菌感染(CDI)微生物组研究经验,综述ARO获得风险、微生物组抵抗定植能力及实验模型验证方法,并提出未来研究方向。

要点

  • 肠道微生物组是影响ARO定植与感染风险的新兴靶点。
  • 借鉴CDI研究经验可加速理解微生物组与ARO的相互作用。
  • 需实验模型系统验证全局性发现以获取机制性认识。

核心结论

  • 肠道微生物组是ARO定植风险和防御感染的新兴靶点,需实验模型验证并推进机制研究。

研究设计与样本

  • 综述类:基于CDI微生物组研究经验,汇总ARO获得风险、微生物组抵抗定植及实验模型验证的现有认识。

主要发现

  • 尽管采取抗菌药物管理、隔离携带者和开发新药等措施,ARO挑战仍持续增长。
  • 肠道微生物组(微生物群与代谢物)是ARO定植风险和防御感染的新兴靶点。

临床怎么用

  • 临床可关注肠道微生物组作为ARO定植与感染风险的潜在干预靶点。
  • 借鉴CDI微生物组研究经验推动ARO相关微生物组研究。

局限性

  • 原文未报告具体研究数据或系统评价方法学细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antimicrobial resistance has become a worldwide medical challenge [1], so impactful that vancomycin-resistant Enterococcus (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) have entered the common vernacular. We have attempted to reduce the selective pressure through antimicrobial stewardship, curtail the spread by identifying and isolating carriers and individuals with symptomatic infection, and treat antibiotic-resistant organisms (AROs) by developing novel antimicrobials. Despite these extraordinary measures, the challenge of AROs continues to grow. The gut microbiome, the ecosystem of microbes (ie, the microbiota) and metabolites present upon and within all humans, is an emerging target for both the risk for colonization and defense against infection with AROs. Here, informed from experiences and successes with understanding the role of the microbiome in mediating risk of Clostridioides difficile infection (CDI), we (1) review our understanding of the risk from ARO acquisition; (2) review our current understanding of the gut microbiome's ability to resist colonization with AROs; (3) describe how experimental model systems can test these initial, global insights to arrive at more granular, mechanistic ones; and (4) suggest a path forward to make further progress in the field.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Golob JL, Rao K. Signal Versus Noise: How to Analyze the Microbiome and Make Progress on Antimicrobial Resistance. J Infect Dis. 2021. PMID: 33880565. doi:10.1093/infdis/jiab184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。